An open randomized controlled study of topical timolol maleate gel for the treatment of infant hemangioma: Comparison of safety and efficacy between topical timolol maleate gel and dye laser
Phase 2
- Conditions
- Infant hemangioma
- Registration Number
- JPRN-UMIN000014761
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have asthma, cardiovascular malformation, diabetes, poor weight gain, medication (including adrenaline, beta-blocker, calcium antagonist agent, digitalis product, CYP2D6 inhibitor), other skin disease, many infant hemangioma, congenital hemangioma. Patients who are ruled unfit to this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method